Greiner Bio-One North America

Greiner Bio-One North America

gbo.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Greiner Bio-One North America is a key player in the pre-analytical and diagnostic device market, operating as a critical supplier to clinical labs and research facilities. The company leverages its parent group's global manufacturing and R&D expertise to offer high-quality, standardized consumables and systems that enhance laboratory workflow efficiency and sample integrity. Its business is built on a recurring revenue model from consumables sales, supported by automation solutions aimed at reducing laboratory operational costs. As a private subsidiary, it focuses on steady growth through product portfolio expansion and deepening customer relationships in the North American market.

DiagnosticsMedical Devices

Technology Platform

Material science and precision manufacturing platform for medical-grade plastics, specializing in closed blood collection systems, polymer surface coatings, and lab automation hardware integration.

Opportunities

Growth is driven by the expansion of laboratory automation to address staffing shortages and improve efficiency, creating demand for integrated consumables and systems.
The rising volume of molecular diagnostic testing (e.g., for oncology, infectious disease) presents a significant opportunity for specialized sample collection and stabilization tubes.

Risk Factors

The company faces intense price competition from larger, diversified players in the medical device market, which can pressure margins.
It is also exposed to supply chain volatility for key raw materials like medical-grade plastics and chemicals, which can disrupt production and increase costs.

Competitive Landscape

Greiner Bio-One competes in a crowded pre-analytical and diagnostic consumables market dominated by global giants like Becton Dickinson (BD), with other significant competitors including Sarstedt, Terumo, and Cardinal Health. Its competitive edge relies on product quality, specialized tube formulations, and a strong focus on automation compatibility, rather than competing solely on scale or price.